|
Market Closed -
Australian S.E.
00:10:28 2026-11-06 EST
|
5-day change | 1st Jan Change | ||
| 0.0210 AUD | 0.00% |
|
-8.70% | -94.94% |
| 10-23 | Immutep Limited Announces Health-Related Quality of Life Data from Eftisarc-Neo Phase Ii Trial | CI |
| 10-13 | Immutep outlines clinical development priorities and plans for 2027 | FI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
- Stock Market
- Stocks
- IMM Stock
- Charts Immutep Limited
- Total Return chart
Select your edition
All financial news and data tailored to specific country editions
